BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Apple
AAPL
|
$2.6B |
| 2 |
POT
Potash Corp Of Saskatchewan
POT
|
$798M |
| 3 |
Invesco QQQ Trust
QQQ
|
$583M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
$578M |
| 5 |
Canadian Pacific Kansas City
CP
|
$560M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$4.1B |
| 2 |
Tesla
TSLA
|
$2.64B |
| 3 |
Equinix
EQIX
|
$2.52B |
| 4 |
SNDK
SANDISK CORP
SNDK
|
$2.15B |
| 5 |
TRLA
TRULIA INC (DEL)
TRLA
|
$2.11B |
Sector Composition
| 1 | Technology | 4.86% |
| 2 | Financials | 3.18% |
| 3 | Industrials | 1.78% |
| 4 | Healthcare | 1.7% |
| 5 | Materials | 1.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Synovus
SNV
$7.16B
| – | – | -258,713 | Closed | -$830K |
|
3502
iShares Semiconductor ETF
SOXX
$13.6B
| – | – | -1,212 | Closed | -$94.8K |
|
3503
Sapiens International
SPNS
$2.4B
| – | – | -139 | Closed | -$1.09K |
|
3504
SiriusPoint
SPNT
$2.19B
| – | – | -65 | Closed | -$1.02K |
|
3505
1st Source
SRCE
$1.58B
| – | – | -58 | Closed | -$1.71K |
|
3506
SouthState
SSB
$10.3B
| – | – | -6 | Closed | -$345 |
|
3507
ProShares Ultra S&P500
SSO
$7.16B
| – | – | -500 | Closed | -$53.3K |
|
3508
Supernus Pharmaceuticals
SUPN
$2.53B
| – | – | -62 | Closed | -$509 |
|
3509
Standex International
SXI
$2.46B
| – | – | -8 | Closed | -$475 |
|
3510
Alaunos Therapeutics
TCRT
$4.21M
| – | – | -84 | Closed | -$302 |
|
3511
First Financial Corporation Common Stock
THFF
$699M
| – | – | -10 | Closed | -$320 |
|
3512
Tandem Diabetes Care
TNDM
$845M
| – | – | -20 | Closed | -$351 |
|
3513
Toro Company
TTC
$8B
| – | – | -218 | Closed | -$13.9K |
|
3514
TotalEnergies
TTE
$137B
| – | – | -2 | Closed | -$142 |
|